{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:51:43Z","timestamp":1793821903724,"version":"4.6.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:00:00Z","timestamp":1704844800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.expneurol.2024.114675","type":"journal-article","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T11:17:19Z","timestamp":1704885439000},"page":"114675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Glucocorticoid receptor antagonist CORT113176 attenuates motor and neuropathological symptoms of Huntington's disease in R6\/2 mice"],"prefix":"10.1016","volume":"374","author":[{"given":"Max","family":"Gentenaar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fleur L.","family":"Meulmeester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximaine R.","family":"van der Burg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna T.","family":"Hoekstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazel","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Kroon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willeke M.C.","family":"van Roon-Mom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onno C.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2024.114675_bb0005","article-title":"Assessing functional performance in the mdx mouse model","volume":"85","author":"Aartsma-Rus","year":"2014","journal-title":"J. Vis. Exp."},{"issue":"4","key":"10.1016\/j.expneurol.2024.114675_bb0010","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.410310412","article-title":"Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington\u2019s disease","volume":"31","author":"Albin","year":"1992","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.expneurol.2024.114675_bb0015","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0166-2236(95)80020-3","article-title":"The functional anatomy of disorders of the basal ganglia","volume":"18","author":"Albin","year":"1995","journal-title":"Trends Neurosci."},{"issue":"1","key":"10.1016\/j.expneurol.2024.114675_bb0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40478-020-0880-6","article-title":"Single-nucleus RNA-seq identifies Huntington disease astrocyte states","volume":"8","author":"Al-Dalahmah","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"issue":"4","key":"10.1016\/j.expneurol.2024.114675_bb0025","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1210\/jc.2008-2543","article-title":"Increased hypothalamic-pituitary-adrenal axis activity in Huntington\u2019s disease","volume":"94","author":"Aziz","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.expneurol.2024.114675_bb0030","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.biopsych.2012.12.003","article-title":"Mifepristone alters amyloid precursor protein processing to preclude amyloid beta and also reduces tau pathology","volume":"74","author":"Baglietto-Vargas","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.expneurol.2024.114675_bb0035","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.neubiorev.2016.09.006","article-title":"Neuroendocrine and neurotrophic signaling in Huntington\u2019s disease: implications for pathogenic mechanisms and treatment strategies","volume":"71","author":"Bartlett","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.expneurol.2024.114675_bb0040","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"9","key":"10.1016\/j.expneurol.2024.114675_bb0045","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1136\/jnnp-2015-312413","article-title":"Hippocampal dysfunction defines disease onset in Huntington\u2019s disease","volume":"87","author":"Begeti","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.expneurol.2024.114675_bb0050","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.psychres.2010.04.030","article-title":"Earliest functional declines in Huntington disease","volume":"178","author":"Beglinger","year":"2010","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.expneurol.2024.114675_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.628010","article-title":"D1R- and D2R-medium-sized spiny neurons diversity: insights into striatal vulnerability to Huntington\u2019s disease mutation","volume":"15","author":"Bergonzoni","year":"2021","journal-title":"Front. Cell. Neurosci."},{"issue":"10","key":"10.1016\/j.expneurol.2024.114675_bb0060","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/hmg\/ddl094","article-title":"Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6\/2 transgenic mouse model of Huntington\u2019s disease","volume":"15","author":"Bjorkqvist","year":"2006","journal-title":"Hum. Mol. Genet."},{"issue":"8","key":"10.1016\/j.expneurol.2024.114675_bb0065","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"Characterization of progressive motor deficits in mice transgenic for the human Huntington\u2019s disease mutation","volume":"19","author":"Carter","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2024.114675_bb0070","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/970204","article-title":"Coexistence of gait disturbances and chorea in experimental Huntington\u2019s disease","volume":"2015","author":"Casaca-Carreira","year":"2015","journal-title":"Behav. Neurol."},{"issue":"12","key":"10.1016\/j.expneurol.2024.114675_bb0075","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/jnr.24503","article-title":"Developmental origins of cortical hyperexcitability in Huntington\u2019s disease: review and new observations","volume":"97","author":"Cepeda","year":"2019","journal-title":"J. Neurosci. Res."},{"issue":"3","key":"10.1016\/j.expneurol.2024.114675_bb0080","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.neuron.2017.06.029","article-title":"Neural circuit-specialized astrocytes: transcriptomic, proteomic, morphological, and functional evidence","volume":"95","author":"Chai","year":"2017","journal-title":"Neuron."},{"issue":"Pt 3","key":"10.1016\/j.expneurol.2024.114675_bb0085","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/brain\/awq328","article-title":"Neuronal degeneration in striatal transplants and Huntington\u2019s disease: potential mechanisms and clinical implications","volume":"134","author":"Cicchetti","year":"2011","journal-title":"Brain."},{"issue":"6","key":"10.1016\/j.expneurol.2024.114675_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21062137","article-title":"Insights into the therapeutic potential of glucocorticoid receptor modulators for neurodegenerative diseases","volume":"21","author":"De Nicola","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.expneurol.2024.114675_bb0095","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00415-005-0929-2","article-title":"Role of hypokinesia and bradykinesia in gait disturbances in Huntington\u2019s disease: a biomechanical study","volume":"253","author":"Delval","year":"2006","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.expneurol.2024.114675_bb0100","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jchemneu.2004.02.005","article-title":"Differential loss of striatal projection systems in Huntington\u2019s disease: a quantitative immunohistochemical study","volume":"27","author":"Deng","year":"2004","journal-title":"J. Chem. Neuroanat."},{"issue":"Pt A","key":"10.1016\/j.expneurol.2024.114675_bb0105","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.expneurol.2016.06.028","article-title":"Corticosterone dysregulation exacerbates disease progression in the R6\/2 transgenic mouse model of Huntington\u2019s disease","volume":"283","author":"Dufour","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2024.114675_bb0110","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.nbd.2018.09.025","article-title":"Normalizing glucocorticoid levels attenuates metabolic and neuropathological symptoms in the R6\/2 mouse model of huntington\u2019s disease","volume":"121","author":"Dufour","year":"2019","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.expneurol.2024.114675_bb0115","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.brainresbull.2010.08.006","article-title":"Hypothalamic-pituitary-adrenal axis functioning in Huntington\u2019s disease mutation carriers compared with mutation-negative first-degree controls","volume":"83","author":"van Duijn","year":"2010","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.expneurol.2024.114675_bb0120","article-title":"Quantification of Huntington\u2019s disease related markers in the R6\/2 mouse model","volume":"13","author":"Etxeberria-Rekalde","year":"2020","journal-title":"Front. Mol. Neurosci."},{"issue":"15","key":"10.1016\/j.expneurol.2024.114675_bb0125","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1093\/hmg\/ddq212","article-title":"In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington\u2019s disease subjects","volume":"19","author":"Faideau","year":"2010","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.expneurol.2024.114675_bb0130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bbi.2006.03.005","article-title":"Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses","volume":"21","author":"Frank","year":"2007","journal-title":"Brain Behav. Immun."},{"issue":"12","key":"10.1016\/j.expneurol.2024.114675_bb0135","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1073\/pnas.81.12.3879","article-title":"RU 486: a steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day","volume":"81","author":"Gaillard","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.expneurol.2024.114675_bb0140","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1111\/j.1460-9568.2008.06310.x","article-title":"Mechanisms of neurodegeneration in Huntington\u2019s disease","volume":"27","author":"Gil","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2024.114675_bb0145","article-title":"A simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia","volume":"39","author":"Guyenet","year":"2010","journal-title":"J. Vis. Exp."},{"issue":"1","key":"10.1016\/j.expneurol.2024.114675_bb0150","doi-asserted-by":"crossref","first-page":"7","DOI":"10.31887\/DCNS.2016.18.1\/shaber","article-title":"Corticostriatal circuitry","volume":"18","author":"Haber","year":"2016","journal-title":"Dialogues Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.expneurol.2024.114675_bb0155","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00005072-199501000-00013","article-title":"Early loss of neostriatal striosome neurons in Huntington\u2019s disease","volume":"54","author":"Hedreen","year":"1995","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"6","key":"10.1016\/j.expneurol.2024.114675_bb0160","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2826.2006.01429.x","article-title":"Do corticosteroids damage the brain?","volume":"18","author":"Herbert","year":"2006","journal-title":"J. Neuroendocrinol."},{"issue":"24","key":"10.1016\/j.expneurol.2024.114675_bb0165","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1016\/j.bmcl.2015.10.097","article-title":"1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as potent GR antagonists with reduced hERG inhibition and an improved pharmacokinetic profile","volume":"25","author":"Hunt","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.expneurol.2024.114675_bb0170","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.mehy.2008.06.036","article-title":"Impact of glucocorticoids and chronic stress on progression of Parkinson\u2019s disease","volume":"71","author":"Kibel","year":"2008","journal-title":"Med. Hypotheses"},{"issue":"2","key":"10.1016\/j.expneurol.2024.114675_bb0175","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archneur.58.2.273","article-title":"Progression of symptoms in the early and middle stages of Huntington disease","volume":"58","author":"Kirkwood","year":"2001","journal-title":"Arch. Neurol."},{"issue":"12","key":"10.1016\/j.expneurol.2024.114675_bb0180","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009621","article-title":"Functional neuroanatomy of the basal ganglia","volume":"2","author":"Lanciego","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"1","key":"10.1016\/j.expneurol.2024.114675_bb0185","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41398-018-0101-2","article-title":"Targeting glucocorticoid receptors prevents the effects of early life stress on amyloid pathology and cognitive performance in APP\/PS1 mice","volume":"8","author":"Lesuis","year":"2018","journal-title":"Transl. Psychiatry"},{"issue":"5","key":"10.1016\/j.expneurol.2024.114675_bb0190","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1006\/nbdi.2001.0430","article-title":"Impaired glutamate uptake in the R6 Huntington\u2019s disease transgenic mice","volume":"8","author":"Lievens","year":"2001","journal-title":"Neurobiol. Dis."},{"issue":"23","key":"10.1016\/j.expneurol.2024.114675_bb0195","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1523\/JNEUROSCI.19-23-10428.1999","article-title":"Selective discrimination learning impairments in mice expressing the human Huntington\u2019s disease mutation","volume":"19","author":"Lione","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2024.114675_bb0200","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.neuroscience.2018.05.042","article-title":"The selective glucocorticoid receptor modulator Cort 113176 reduces neurodegeneration and Neuroinflammation in wobbler mice spinal cord","volume":"384","author":"Meyer","year":"2018","journal-title":"Neuroscience."},{"key":"10.1016\/j.expneurol.2024.114675_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2019.146551","article-title":"Long-term effects of the glucocorticoid receptor modulator CORT113176 in murine motoneuron degeneration","volume":"1727","author":"Meyer","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2024.114675_bb0210","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bbr.2013.07.041","article-title":"Short-term memory acquisition in female Huntington\u2019s disease mice is vulnerable to acute stress","volume":"253","author":"Mo","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2024.114675_bb0215","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.nbd.2014.07.008","article-title":"Effects of chronic stress on the onset and progression of Huntington\u2019s disease in transgenic mice","volume":"71","author":"Mo","year":"2014","journal-title":"Neurobiol. Dis."},{"issue":"9","key":"10.1016\/j.expneurol.2024.114675_bb0220","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1023\/A:1010887421592","article-title":"Progressive formation of inclusions in the striatum and hippocampus of mice transgenic for the human Huntington\u2019s disease mutation","volume":"29","author":"Morton","year":"2000","journal-title":"J. Neurocytol."},{"issue":"13","key":"10.1016\/j.expneurol.2024.114675_bb0225","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1523\/JNEUROSCI.20-13-05115.2000","article-title":"Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington\u2019s disease mutation","volume":"20","author":"Murphy","year":"2000","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.expneurol.2024.114675_bb0230","doi-asserted-by":"crossref","first-page":"71","DOI":"10.14802\/jmd.16005","article-title":"Movement disorders following cerebrovascular lesion in the basal ganglia circuit","volume":"9","author":"Park","year":"2016","journal-title":"J. Mov. Disord."},{"issue":"1","key":"10.1016\/j.expneurol.2024.114675_bb0235","doi-asserted-by":"crossref","DOI":"10.2217\/fnl.09.78","article-title":"Early detection of Huntington disease","volume":"5","author":"Paulsen","year":"2010","journal-title":"Future Neurol."},{"issue":"4","key":"10.1016\/j.expneurol.2024.114675_bb0240","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/glia.20207","article-title":"Astrocyte activation and reactive gliosis","volume":"50","author":"Pekny","year":"2005","journal-title":"Glia."},{"key":"10.1016\/j.expneurol.2024.114675_bb0245","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neurobiolaging.2016.05.018","article-title":"New selective glucocorticoid receptor modulators reverse amyloid-beta peptide-induced hippocampus toxicity","volume":"45","author":"Pineau","year":"2016","journal-title":"Neurobiol. Aging"},{"issue":"6","key":"10.1016\/j.expneurol.2024.114675_bb0250","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/bpa.12432","article-title":"Cognitive dysfunction in Huntington\u2019s disease: mechanisms and therapeutic strategies beyond BDNF","volume":"26","author":"Puigdellivol","year":"2016","journal-title":"Brain Pathol."},{"issue":"5","key":"10.1016\/j.expneurol.2024.114675_bb0255","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1210\/endo.136.5.7720656","article-title":"Transcriptional regulation of glial fibrillary acidic protein by corticosterone in rat astrocytes in vitro is influenced by the duration of time in culture and by astrocyte-neuron interactions","volume":"136","author":"Rozovsky","year":"1995","journal-title":"Endocrinology."},{"issue":"2","key":"10.1016\/j.expneurol.2024.114675_bb0260","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0306-4522(94)00427-7","article-title":"Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington\u2019s disease using high resolution image analysis","volume":"64","author":"Sapp","year":"1995","journal-title":"Neuroscience."},{"issue":"10","key":"10.1016\/j.expneurol.2024.114675_bb0265","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/j.biocel.2013.05.036","article-title":"Glucocorticoid-induced skeletal muscle atrophy","volume":"45","author":"Schakman","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"5","key":"10.1016\/j.expneurol.2024.114675_bb0270","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2174\/1389450120666191017114735","article-title":"Navigating Alzheimer\u2019s disease via chronic stress: the role of glucocorticoids","volume":"21","author":"Sharma","year":"2020","journal-title":"Curr. Drug Targets"},{"issue":"4","key":"10.1016\/j.expneurol.2024.114675_bb0275","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3233\/JHD-210474","article-title":"Housing R6\/2 mice with wild-type littermates increases lifespan","volume":"10","author":"Story","year":"2021","journal-title":"J. Huntingtons. Dis."},{"issue":"6","key":"10.1016\/j.expneurol.2024.114675_bb0280","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.mehy.2009.02.047","article-title":"Stress-induced microglial activation may facilitate the progression of neurodegenerative disorders","volume":"73","author":"Sugama","year":"2009","journal-title":"Med. Hypotheses"},{"issue":"2","key":"10.1016\/j.expneurol.2024.114675_bb0285","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41380-019-0609-8","article-title":"Microglial regional heterogeneity and its role in the brain","volume":"25","author":"Tan","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.expneurol.2024.114675_bb0290","article-title":"Juvenile Huntington\u2019s disease masquerading as progressive myoclonus epilepsy","volume":"16","author":"Thakor","year":"2021","journal-title":"Epilepsy Behav. Rep."},{"key":"10.1016\/j.expneurol.2024.114675_bb0295","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yebeh.2019.02.029","article-title":"PTZ-induced seizures in mice require a revised Racine scale","volume":"95","author":"Van Erum","year":"2019","journal-title":"Epilepsy Behav."},{"issue":"2","key":"10.1016\/j.expneurol.2024.114675_bb0300","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/endrev\/bnz005","article-title":"The role of sex and sex hormones in neurodegenerative diseases","volume":"41","author":"Vegeto","year":"2020","journal-title":"Endocr. Rev."},{"issue":"1\u20132","key":"10.1016\/j.expneurol.2024.114675_bb0305","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mce.2007.05.015","article-title":"Glucocorticoids, metabolism and metabolic diseases","volume":"275","author":"Vegiopoulos","year":"2007","journal-title":"Mol. Cell. Endocrinol."},{"issue":"5","key":"10.1016\/j.expneurol.2024.114675_bb0310","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2024.114675_bb0315","doi-asserted-by":"crossref","first-page":"6391686","DOI":"10.1155\/2016\/6391686","article-title":"Chronic stress and glucocorticoids: from neuronal plasticity to neurodegeneration","volume":"2016","author":"Vyas","year":"2016","journal-title":"Neural Plast."},{"key":"10.1016\/j.expneurol.2024.114675_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104963","article-title":"The contribution of glial cells to Huntington\u2019s disease pathogenesis","volume":"143","author":"Wilton","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2024.114675_bb0325","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3389\/fneur.2020.00571","article-title":"Gender differences in non-sex linked disorders: insights from Huntington\u2019s disease","volume":"11","author":"Zielonka","year":"2020","journal-title":"Front. Neurol."},{"issue":"2","key":"10.1016\/j.expneurol.2024.114675_bb0330","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.parkreldis.2012.09.012","article-title":"The influence of gender on phenotype and disease progression in patients with Huntington\u2019s disease","volume":"19","author":"Zielonka","year":"2013","journal-title":"Parkinsonism Relat. Disord."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488624000013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488624000013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T04:57:33Z","timestamp":1772686653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488624000013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":66,"alternative-id":["S0014488624000013"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2024.114675","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucocorticoid receptor antagonist CORT113176 attenuates motor and neuropathological symptoms of Huntington's disease in R6\/2 mice","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2024.114675","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114675"}}